In the US, ReoPro (abciximab systemic) is a member of the drug class glycoprotein platelet inhibitors and is used to treat High Risk Percutaneous Transluminal Angioplasty.
Ingredient matches for ReoPro
Abciximab is reported as an ingredient of ReoPro in the following countries:
- Czech Republic
- Hong Kong
- New Zealand
- South Africa
- United Kingdom
← International Drug Name Search
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.